Nutriproteomics - linking proteomics variation with personalized nutrition

Current Pharmacogenomics and Personalized Medicine

Volumn 8, Issue 4, 2010, Pages 245-256

  Kussmann, Martin ^a,b  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Biomarker; Biotechnology; Health promotion; Nutriproteomics; Nutrition; Personalized nutrition; Proteomics

Indexed keywords

ALPHA LACTALBUMIN; CD14 ANTIGEN; CD4 ANTIGEN; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE; JANUS KINASE; PEPTIDE DERIVATIVE; SAPONIN; TOLL LIKE RECEPTOR 2;

ALLERGY; ARTICLE; BREAST MILK; CEREAL; DAIRY PRODUCT; ESCHERICHIA COLI; FOOD; HUMAN; IMMUNITY; IRRITABLE COLON; LACTOBACILLUS; LEGUME; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MACRONUTRIENT; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL RESEARCH; MILK PRODUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; OBESITY; PROTEIN EXPRESSION; PROTEOMICS; SOYBEAN;

EID: 84857224185     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569210793368177     Document Type: Article

References (126)

1. Kussmann M, Raymond F, Affolter M. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 2006; 124: 758-87.
2. Kussmann M, Daniel H. Editorial overview. Curr Opin Biotechnol 2008; 19: 63-5.
3. Kussmann M, Fay LB. Nutrigenomics and personalized nutrition: science and concept. Per Med 2008; 5: 447-55.
4. Kussmann M, Affolter M, Nagy K, et al. Mass spectrometry in nutrition: understanding dietary health effects at the molecular level. Mass Spectrom Rev 2007; 26: 727-50.
5. Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet 2004; 5: 71-118.
6. Kussmann M, Affolter M. Proteomic methods in nutrition. Curr Opin Clin Nutr Metab Care 2006; 9: 575-83.
7. Kussmann M, Affolter M, Fay LB. Proteomics in nutrition and health. Comb Chem High Throughput Screen 2005; 8: 679-96.
8. Fong BY, Norris CS, Palmano KP. Fractionation of bovine whey proteins and characterisation by proteomic techniques. Int Dairy J 2008; 18: 23-46.
9. Gao L, Wang A, Li X, et al. Wheat quality related differential expressions of albumins and globulins revealed by twodimensional difference gel electrophoresis (2-D DIGE). J Proteomics 2009; 73: 279-96.
10. Sakata K, Ohyanagi H, Nobori H, et al. Soybean proteome database: a data resource for plant differential omics. J Proteome Res 2009; 8: 3539-48.
11. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesityassociated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-31.
12. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4: 478-85.
13. Huyghe A, Francois P, Charbonnier Y, et al. Novel microarray design strategy to study complex bacterial communities. Appl Environ Microbiol 2008; 74: 1876-85.
14. Hamady M, Knight R. Microbial community profiling for human microbiome projects: Tools, techniques, and challenges. Genome Res 2009; 19: 1141-52.
15. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-4.
16. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol 2009; 587: 4153-8.
17. VerBerkmoes NC, Russell AL, Shah M, et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J 2009; 3: 179-89.
18. Schlimme E, Meisel H. Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Nahrung 1995; 39: 1-20.
19. Meisel H, Bockelmann W. Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie Van Leeuwenhoek 1999; 76: 207-15.
20. Moller NP, Scholz-Ahrens KE, Roos N, et al. Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr 2008; 47: 171-82.
21. Minkiewicz P, Dziuba J, Iwaniak A, et al. BIOPEP database and other programs for processing bioactive peptide sequences. J AOAC Int 2008; 91: 965-80.
22. Meisel H. Multifunctional peptides encrypted in milk proteins. Biofactors 2004; 21: 55-61.
23. Autelitano DJ, Rajic A, Smith AI, et al. The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities. Drug Discov Today 2006; 11: 306-14.
24. German JB, Morgan CJ, Ward RE. Milk: a model for nutrition in the 21st century. Aust J Dairy Tech 2003; 58: 49-54.
25. Severin S, Xia W. Milk biologically active components as nutraceuticals: review. Crit Rev Food Sci Nutr 2005; 45: 645-56.
26. German JB, Dillard CJ. Composition, structure and absorption of milk lipids: a source of energy, fat-soluble nutrients and bioactive molecules. Crit Rev Food Sci Nutr 2006; 46: 57-92.
27. Ninonuevo MR, Youmie P, Hongfeng Y, et al. A strategy for annotating the human milk glycome. J Agric Food Chem 2006; 54: 7471-80.
28. Madureira AR, Pereira CI, Gomes A-MP, et al. Bovine whey proteins Overview on their main biological properties. Food Res Int 2007; 40: 1197-211.
29. Casado B, Affolter M, Kussmann M. OMICS-rooted studies of milk proteins, oligosaccharides and lipids. J Proteomics 2009; 73: 196-208.
30. Alomirah HF, Alli I, Konishi Y. Applications of mass spectrometry to food proteins and peptides [Review]. J Chrom A 2000; 893: 1-21.
31. Ferranti P. Mass spectrometric approach for the analysis of food proteins. Eur J Mass Spectrom 2004; 10: 349-58.
32. Guy PA, Fenaille F. Contribution of mass spectrometry to assess quality of milk-based products. Mass Spectrom Rev 2006; 25: 290-326.
33. Farnaud S, Evans RW. Lactoferrin--a multifunctional protein with antimicrobial properties. Mol Immunol 2003; 40: 395-405.
34. Crouch SP, Slater KJ, Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 1992; 80: 235-40.
35. Erdmann K, Cheung BW, Schroder H. The possible roles of foodderived bioactive peptides in reducing the risk of cardiovascular disease. J Nutr Biochem 2008; 19: 643-54.
36. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 1996; 126: 3063-68.
37. D'Auria E, Agostoni C, Giovannini M, et al. Proteomic evaluation of milk from different mammalian species as a substitute for breast milk. Acta Paediatr 2005; 94: 1708-13.
38. Peng L, Rawson P, McLauchlan D, et al. Proteomic analysis of microsomes from lactating bovine mammary gland. J Proteome Res 2008; 7: 1427-32.
39. Liu T, Qian WJ, Chen WN, et al. Improved proteome coverage by using high efficiency cysteinyl peptide enrichment: the human mammary epithelial cell proteome. Proteomics 2005; 5: 1263-73.
40. Levy J. Immunonutrition: the pediatric experience. Nutrition 1998; 14: 641-7.
41. Labeta MO, Vidal K, Nores JE, et al. Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J Exp Med 2000; 191: 1807-12.
42. Vidal K, Labeta MO, Schiffrin EJ, et al. Soluble CD14 in human breast milk and its role in innate immune responses. Acta Odontol Scand 2001; 59: 330-34.
43. LeBouder E, Rey-Nores JE, Rushmere NK, et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003; 171: 6680-9.
44. Panchaud A, Kussmann M, Affolter M. Rapid enrichment of bioactive milk proteins and iterative, consolidated protein identification by multidimensional protein identification technology. Proteomics 2005; 5: 3836-46.
45. Erickson BE. Proteomics data back up soy health claims. J Proteome Res 2005; 4: 219.
46. Fang N, Yu S, Badger TM. Comprehensive phytochemical profile of soy protein isolate. J Agric Food Chem 2004; 52: 4012-20.
47. Park JH, Jeong HJ, de Lumen BO. Contents and bioactivities of lunasin, bowman-birk inhibitor, and isoflavones in soybean seed. J Agric Food Chem 2005; 53: 7686-90.
48. de Lumen BO. Lunasin: a cancer-preventive soy peptide. Nutr Rev 2005; 63: 16-21.
49. Gianazza E, Eberini I, Arnoldi A, et al. A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies. J Nutr 2003; 133: 9-14.
50. Fuchs D, de Pascual-Teresa S, Rimbach G, et al. Proteome analysis for identification of target proteins of genistein in primary human endothelial cells stressed with oxidized LDL or homocysteine. Eur J Nutr 2005; 44: 95-104.
51. Fuchs D, Vafeiadou K, Hall WL, et al. Proteomic biomarkers of peripheral blood mononuclear cells obtained from postmenopausal women undergoing an intervention with soy isoflavones. Am J Clin Nutr 2007; 86: 1369-75.
52. Astle J, Ferguson JT, German JB, et al. Characterization of proteomic and metabolomic responses to dietary factors and supplements. J Nutr 2007; 137: 2787-93.
53. Beermann C, Euler M, Herzberg J, et al. Anti-oxidative capacity of enzymatically released peptides from soybean protein isolate. Eur Food Res Technol 2009; 229: 637-44.
54. Aderem A, Smith KD. A systems approach to dissecting immunity and inflammation. Semin Immunol 2004; 16: 55-67.
55. Tjalsma H, Schaeps RMJ, Swinkels DW. Immunoproteomics: From biomarker discovery to diagnostic applications. Proteomics Clin Appl 2008; 2: 167-80.
56. de Roos B, McArdle HJ. Proteomics as a tool for the modelling of biological processes and biomarker development in nutrition research. Br J Nutr 2008; 99 (Suppl 3): S66-S71.
57. Song K, Hanash S. Unraveling the complex proteome for biomarker discovery in gastrointestinal and liver diseases. Gastroenterology 2007; 131: 1375-78.
58. Purcell AW, Gorman JJ. Immunoproteomics: Mass spectrometrybased methods to study the targets of the immune response. Mol Cell Proteomics 2004; 3: 193-208.
59. Weingarten P, Lutter P, Wattenberg A, et al. Application of proteomics and protein analysis for biomarker and target finding for immunotherapy. Meth Mol Med 2005; 109: 155-74.
60. Kubach J, Lutter P, Bopp T, et al. Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 2007; 110: 1550-58.
61. Kussmann M, Blum-Sperisen S. OMICS-Derived targets for inflammatory gut disorders: opportunities for the development of nutrition related biomarkers. Endocr Metab Immune Disord Drug Targets 2007; 7: 271-87.
62. Henson PM. Dampening inflammation. Nat Immunol 2005; 6: 1179-81.
63. James SP. Prototypic disorders of gastrointestinal mucosal immune function: Celiac disease and Crohn's disease. J Allergy Clin Immunol 2005; 115: 25-30.
64. Danielsen M, Thymann T, Jensen BB, et al. Proteome profiles of mucosal immunoglobulin uptake in inflamed porcine gut. Proteomics 2006; 6: 6588-96.
65. Danielsen M, Hornshoej H, Siggers RH et al. Effects of bacterial colonization on the porcine intestinal proteome. J Proteome Res 2007; 6: 2596-604.
66. Thebault S, Deniel N, Marion R, et al. Proteomic analysis of glutamine-treated human intestinal epithelial HCT-8 cells under basal and inflammatory conditions. Proteomics 2006; 6: 3926-37.
67. Deniel N, Marion-Letellier R, Charlionet R, et al. Glutamine regulates the human epithelial intestinal HCT-8 cell proteome under apoptotic conditions. Mol Cell Proteomics 2007; 6: 1671-79.
68. Eigenmann PA. Food allergy: a long way to safe processed foods. Allergy 2001; 56: 1112-3.
69. Chandra RK. Food hypersensitivity and allergic disease: a selective review. Am J Clin Nutr 1997; 66: 526S-9S.
70. Blüggel M, Spertini F, Lutter P, et al. Towards protein biomarkers for allergy: CD4+ T cell proteomics in allergic and non-allergic subjects sampled in and out of pollen season. Submitted.
71. Tataranni PA, Ravussin E. Energy metabolism and obesity. In Handbook of obesity treatment. Wadden TA, Stunkard AJ. Eds. New York: Guilford Press; 2002: vol. 42.
72. Tataranni PA, Borgadus C. Obesity and diabetes mellitus. In 6 ed Eds. Porte DJ, Sherwin RS, Baron A. New York: McGraw-Hill; 2003: vol. 401.
73. Affolter M, Kussmann M. Proteomic and metabonomic routes towards obesity. In Obesity - Genomics and Postgenomics. Soerensen TIA, Clement K. Eds. New York: Informa Health Care; 2008: 527-36.
74. Metz TO, Jacobs JM, Gritsenko MA, et al. Characterization of the human pancreatic islet proteome by two-dimensional LC/MS/MS. J Proteome Res 2006; 5: 3345-54.
75. Sundsten T, Ortsater H. Proteomics in diabetes research. Mol Cell Endocrinol 2009; 297: 93-103.
76. Rao PV, Reddy AP, Lu X, et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res 2009; 8: 239-45.
77. Hwang H, Bowen BP, Lefort N, et al. Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes 2010; 59: 33-42.
78. Birner-Gruenberger R, Hermetter A. Activity-based proteomics of lipolytic enzymes. Curr Drug Discov Technol 2007; 4: 1-11.
79. Sparre T, Bergholdt R, Nerup J, et al. Application of genomics and proteomics in Type 1 diabetes pathogenesis research. Exp Rev Mol Diagn 2003; 3: 743-57.
80. Larsen PM, Fey SJ, Larsen MR, et al. Proteome analysis of interleukin-1beta--induced changes in protein expression in rat islets of Langerhans. Diabetes 2001; 50: 1056-63.
81. Sparre T, Christensen UB, Mose LP, et al. IL-1beta induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysis. Diabetologia 2002; 45: 1550-61.
82. Freiesleben DB, Bak P, Pociot F, et al. Onset of type 1 diabetes: a dynamical instability. Diabetes 1999; 48: 1677-85.
83. Kim S, Moustaid-Moussa N. Secretory, ebdocrine and autocrine/ paracrine function of the adipocyte. J Nutr 2000; 130: 3110S.
84. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
85. Adachi J, Kumar C, Zhang YL, et al. In-depth analysis of the adipocyte proteome by mass spectrometry and bioinformatics. Mol Cell Proteomics 2007; 6: 1257-73.
86. Kim J, Choi YS, Lim S, et al. Comparative analysis of the secretory proteome of human adipose stromal vascular fraction cells during adipogenesis. Proteomics 2010; 10: 394-405.
87. Birner-Gruenberger R, Susani-Etzerodt H, Waldhuber M, et al. The lipolytic proteome of mouse adipose tissue. Mol Cell Proteomics 2005; 4: 1710-17.
88. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998; 22: 1145.
89. Kratchmarova I, Kalume DE, Blagoev B, et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002; 1: 213-22.
90. Perez-Perez R, Ortega-Delgado FJ, Garcia-Santos E, et al. Differential proteomics of omental and subcutaneous adipose tissue reflects their unalike biochemical and metabolic properties. J Proteome Res 2009; 8: 1682-93.
91. Peral B, Camafeita E, Fernandez-Real JM, et al. Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies. Exp Rev Proteomics 2009; 6: 353-61.
92. Garcia-Bailo B, Toguri C, Eny KM, et al. Genetic variation in taste and its influence on food selection. OMICS 2009; 13: 69-80.
93. Gil M, De Marco RJ. Apis mellifera bees acquire long-term olfactory memories within the colony. Biol Lett 2006; 2: 98-100.
94. Rakicioglu N, Samur G, Topcu A, et al. The effect of Ramadan on maternal nutrition and composition of breast milk. Pediatr Int 2006; 48: 278-83.
95. Koebnick C, Garcia AL, Dagnelie PC, et al. Long-term consumption of a raw food diet is associated with favorable serum LDL cholesterol and triglycerides but also with elevated plasma homocysteine and low serum HDL cholesterol in humans. J Nutr 2005; 135: 2372-78.
96. Krebs NF, Westcott JE, Butler N, et al. Meat as a first complementary food for breastfed infants: feasibility and impact on zinc intake and status. J Pediatr Gastroenterol Nutr 2006; 42: 207-14.
97. Murray B. The role of salt and glucose replacement drinks in the marathon. Sports Med 2007; 37: 358-60.
98. Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 2007; 86: 285-300.
99. Zhang J, Munger RG, West NA, et al. Antioxidant intake and risk of osteoporotic hip fracture in Utah: an effect modified by smoking status. Am J Epidemiol 2006; 163: 9-17.
100. Wahn U, von Mutius E, Lau S, et al. The development of atopic phenotypes: genetic and environmental determinants. Nestle Nutr Workshop Ser Pediatr Program 2007; 59: 1-11.
101. Purnell H. Phenylketonuria and maternal phenylketonuria. Breastfeed Rev 2001; 9: 19-21.
102. Wilcken B, Wiley V, Hammond J, et al. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 2003; 348: 2304-12.
103. Weigel C, Rauh M, Kiener C, et al. Effects of various dietary amino acid preparations for phenylketonuric patients on the metabolic profiles along with postprandial insulin and ghrelin responses. Ann Nutr Metab 2007; 51: 352-58.
104. Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 2005; 56: 17-28.
105. Fuchs D, Winkelmann I, Johnson IT, et al. Proteomics in nutrition research: principles, technologies and applications. Br J Nutr 2005; 94: 302-14.
106. Kussmann M, Affolter M. Proteomics and metabonomics routes towards obesity. In Obesity Genomics and Postgenomics. Edited by Sorensen CK Ed. Informa Press; 2008: 527-35.
107. Fuchs D, Piller R, Linseisen J, et al. The human peripheral blood mononuclear cell proteome responds to a dietary flaxseedintervention and proteins identified suggest a protective effect in atherosclerosis. Proteomics 2007; 7: 3278-88.
108. Breikers G, van Breda SG, Bouwman FG, et al. Potential protein markers for nutritional health effects on colorectal cancer in the mouse as revealed by proteomics analysis. Proteomics 2006; 6: 2844-52.
109. tom-Dieck H, Doring F, Fuchs D, et al. Transcriptome and proteome analysis identifies the pathways that increase hepatic lipid accumulation in zinc-deficient rats. J Nutr 2005; 135: 199-205.
110. Lescuyer P, Hochstrasser D, Rabilloud T. How shall we use the proteomics toolbox for biomarker discovery? J Proteome Res 2007; 6: 3371-76.
111. Mischak H. Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl 2007; 1: 148-56.
112. Fay LB, Kussmann M. Mass spectrometry and nutrition research, edn 1. Edited by Fay LB, Kussmann M. Cambridge, UK: Royal Society of Chemistry; 2010.
113. Panchaud A, Scherl A, Shaffer SA, et al. Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean. Anal Chem 2009; 81: 6481-88.
114. Bern M, Finney G, Hoopmann MR, et al. Deconvolution of mixture spectra from ion-trap data-independent-acquisition tandem mass spectrometry. Anal Chem 2010; 82: 833-41.
115. Geromanos SJ, Vissers JP, Silva JC, et al. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics 2009; 9: 1683-95.
116. Hoopmann MR, Merrihew GE, von Haller PD, et al. Post analysis data acquisition for the iterative MS/MS sampling of proteomics mixtures. J Proteome Res 2009; 8: 1870-75.
117. Cham MJ, Bianco L, Bessant C. Free computational resources for designing selected reaction monitoring transitions. Proteomics 2010; 10: 1106-26.
118. Picotti P, Rinner O, Stallmach R, et al. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods 2010; 7: 43-6.
119. Panchaud A, Affolter M, Moreillon P, et al. Experimental and computational approaches to quantitative proteomics: status quo and outlook. J Proteomics 2008; 71: 19-33.
120. Staab CA, Ceder R, Jagerbrink T, et al. Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma. J Proteome Res 2007; 6: 3705-17.
121. Nicholson JK, Connelly J, Lindon JC, et al. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002; 1: 153-61.
122. Affolter M. Mass spectrometry, nutrition and protein turnover. In Mass spectrometry and nutrition research, 1 ed. Fay LB, Kussmann M. Eds. Cambridge, UK: Royal Society of Chemistry; 2010: 310-26.
123. Doherty MK, Beynon RJ. Protein turnover on the scale of the proteome. Exp Rev Proteomics 2006; 3: 97-110.
124. Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 2005; 56: 17-28.
125. Chen Y, Rollins J, Paigen B, et al. Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metab 2007; 6: 64-79.
126. Holtmann G, Siffert W, Haag S, et al. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 2004; 126: 971-9.